Zobrazeno 1 - 10
of 26
pro vyhledávání: '"A. C. S. A. Herrera"'
Autor:
J. Carla-da-Silva, A. C. S. A. Herrera, J. A. O. Souza, T. B. Scandolara, P. L. Micheletti, Rodrigo Kern, Vanessa Jacob Victorino, Isaias Dichi, Jessica Malanowski, A. N. C. Simão, Carolina Panis, Daniel Rech, Vinícius Dias Alves
Publikováno v:
Journal of Chemotherapy. 33:106-115
This study aimed to evaluate markers of cardiac damage (total CK, CKMB and CRP), inflammatory markers (free iron, homocysteine and TNF-α) as well as lipidogram in breast cancer patients undergoing acute cycles of doxorubicin (DOX), paclitaxel (PTX)
Autor:
Daniel Rech, Durcelina Schiavoni Bortoloti, Pâmella Lonardoni Micheletti, A. C. S. A. Herrera, Andréa Name Colado Simão, Carolina Panis, Vanessa Jacob Victorino, Bruno R. B. Pires, Adma Poliana de Borba Cecílio da Silva, Isaias Dichi, Rodrigo Kern
Publikováno v:
Archives of medical research. 51(6)
Purpose In this study, we investigated the circulating levels of 25-hydroxyvitamin D (25[OH]D) in Brazilian women with breast cancer in samples collected at diagnosis, and correlated these with clinicopathological parameters relevant to disease progn
Autor:
Carolina Panis, Renata Binato, Vinícius Dias Alves, Rubens Cecchini, Luciana Pizzatti, Bruno R. B. Pires, Eliana Abdelhay, A. C. S. A. Herrera
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Breast cancer is the leading cause of cancer-associated death among women worldwide. Its high mortality rate is related to resistance towards chemotherapies, which is one of the major challenges of breast cancer research. In this study, we used label
Autor:
A. N. C. Simão, Rubens Cecchini, A. C. S. A. Herrera, Vanessa Jacob Victorino, Carolina Panis, Alessandra Lourenço Cecchini, Luciana Yuki Tomita
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2016 (2016)
Oxidative Medicine and Cellular Longevity
Web of Science
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Oxidative Medicine and Cellular Longevity
Web of Science
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2018-11-26T15:28:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2016-01-01 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq
Autor:
Luciana Pizzatti, A. C. S. A. Herrera, Stephany Corrêa, Rubens Cecchini, Teresa Fernandes Seixas, Eliana Abdelhay, Carolina Panis, Renata Binato, Gabriela Ferreira Lemos
Publikováno v:
Cancer Letters. 357:186-195
Overexpression of human epithelial growth factor receptor 2 (HER2) is a poor prognostic factor in breast cancer. HER2 is a transmembrane receptor comprising an extracellular domain (ECD), a single transmembrane domain, and an intracellular domain (IC
Autor:
Andréa Name Colado Simão, Rubens Cecchini, Carolina Panis, Vanessa Jacob Victorino, Lauana Greicy Tonon Lemos, A. C. S. A. Herrera, Sayonara Rangel Oliveira, Adriano Martin Felis Aranome, Eliana Abdelhay, Alessandra Lourenço Cecchini, Beatriz D. Verenitach, F. C. Campos
Publikováno v:
Clinical Breast Cancer. 14:451-459
Background Recent studies have suggested a regulatory role for some of the metabolites derived from oxidative stress in breast cancer. In this way, cancer-induced oxidative changes could modify the breast environment and potentially trigger systemic
Autor:
Carolina Panis, A. C. S. A. Herrera, Stephany Corrêa, Vanessa Jacob Victorino, Renata Binato, V. Dias-Alves, Rubens Cecchini, A. N. C. Simão, Eliana Abdelhay, Luciana Pizzatti, Décio Sabbatini Barbosa
Publikováno v:
Cancer chemotherapy and pharmacology. 80(3)
Although paclitaxel-based chemotherapy is widely used for treating breast cancer, paclitaxel therapy has been associated with several adverse effects. Such adverse effects have primarily been associated with long-term regimens, but some acute effects
Autor:
Rubens Cecchini, Carolina Panis, Adriano Martin Felis Aranome, A. C. S. A. Herrera, F. C. Campos, Vanessa Jacob Victorino
Publikováno v:
American Journal of Immunology. 10:176-182
About 20% of breast cancer patients overexpress the Human Epidermal growth factor Receptor-2 (HER2), also known as ErbB2. HER2-overexpression is associated with enhanced tumor malignancy and its overexpression is related to specific target therapy ag
Autor:
Alda Losi Guembarovski, A. C. S. A. Herrera, Roberta Losi Guembarovski, Walter Jorge Sobrinho, Karen Brajão de Oliveira, Maria Angelica Ehara Watanabe, Júlio César Voltarelli, Marla Karine Amarante
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Under many circumstances, the host constituents that are found in the tumor microenvironment support a malignancy network and provide the cancer cells with advantages in proliferation, invasiveness and metastasis establishment at remote organs. It is
Autor:
Kalil Alves de Lima, A. C. S. A. Herrera, Roberta Losi Guembarovski, Daniela Rudgeri Derossi, Maria Angelica Ehara Watanabe, Julie Massayo Maeda Oda, Alda Losi Guembarovski, Karen Brajão de Oliveira, Walter Jorge Sobrinho
Publikováno v:
Molecular Biology Reports. 39:10131-10137
The role of chemokines and the growth factors has been extensively analyzed both in cancer risk and tumor progression. The transforming growth factor beta (TGF-β) and chemokine (C-X-C motif) receptor 4 (CXCR4) genes are implicated in several disease